Battle Road's healthcare coverage features medical device makers, as well as software and biotech providers. "The demand to achieve healthier and longer lives is driving numerous advances in the healthcare industry. We are pleased to offer our clients an independent voice on this dynamic, innovative sector" said Ben Z. Rose, president of Battle Road Research.

Battle Road's expanded healthcare coverage is infused with a local New England flavor and includes Boston Scientific (NYSE: BSX), Hologic (NASDAQ: HOLX), Waters (NYSE: WAT), Haemonetics (NYSE: HAE), Zoll Medical (NASDAQ: ZOLL), as well as athenahealth (NASDAQ: ATHN), Phase Forward (NASDAQ: PFWD), and Genzyme (NASDAQ: GENZ). Other companies include WebMD Health (NASDAQ: WBMD), and Illumina (NASDAQ: ILMN).

Battle Road's recently launched blog, which may be visited at www.battleroadblog.com, provides commentary on stocks within each of the four dynamic sectors in Battle Road's coverage. These include Battle of the Book, which discusses the paths taken by Apple (NASDAQ: AAPL), Google (NASDAQ: GOOG), and Amazon.com (NASDAQ: AMZN), to dominate the distribution of digital content; Earnings Skeptic, which highlights companies that may be stretching to achieve earnings results, Full Disclosure, a periodic review of noteworthy financial disclosures gleaned from company SEC filings, as well as the Battle Road Tech Index, which tracks the weekly performance of 25 of the most dynamic stocks in the sector.

"I wish to commend the hardworking Battle Road team, Dave Arcaro, Matt Galinko, Matt Schultze, and Young Li, who have placed us on the map in the healthcare sector, and who continue to evolve our coverage across the board," said Rose. "We look forward to serving our clients with an independent voice on the stocks that we research.

Unlike many of our competitors whose research remains intertwined with an investment banking agenda, Battle Road clients can rely on the fact that we do not receive ”nor do we intend to seek” compensation from any of the companies in our coverage."

About Battle Road Research:

Battle Road Research, an equity research firm, serves fund managers, analysts, and financial advisors with an independent voice on 76 technology, healthcare, solar power, and education stocks. Battle Road analysts place an equal weight on industry and securities analysis in an effort to seek out stocks to buy and stocks to avoid. We present our research conclusions in a straight-forward Buy, Hold, Sell format. As a matter of principle, Battle Road Research refrains from investment banking, company-paid reports, and personal investment in stocks that we research. Visit us on the web at www.battleroad.com, and www.battleroadblog.com.

A service of YellowBrix, Inc.